TROGLITAZONE WITH/WITHOUT INSULIN FOR INSULIN REQUIRING PATIENTS WITH NIDDM

  • Rowe, John (PI)

Project Details

Description

This 26-week double-blind, placebo-controlled, multicenter clinical trial will determine if the addition of Troglitazone, an oral medication, can decrease or eliminate the need for insulin in NIDDM patients taking insulin.
StatusFinished
Effective start/end date1/10/9730/09/99

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.